The Enterprise Value as of December 2025 (TTM) for Vectorite Biomedical Inc. (4170.TWO) is 599.37M

According to Vectorite Biomedical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 599.37M. This represents a change of -9.32% compared to the average of 661.00M of the last 4 quarters.

Vectorite Biomedical Inc. (4170.TWO) Historical Enterprise Value (quarterly & annually)

How has 4170.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Vectorite Biomedical Inc. over the last ten years is 520.82M. The current 599.37M Enterprise Value has changed 11.41% with respect to the historical average. Over the past ten years (40 quarters), 4170.TWO's Enterprise Value was at its highest in in the December 2023 quarter at 823.85M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Vectorite Biomedical Inc. (4170.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vectorite Biomedical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vectorite Biomedical Inc. (4170.TWO) Average Enterprise Value

How has 4170.TWO Enterprise Value performed in the past?

The current Enterprise Value of Vectorite Biomedical Inc. (4170.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vectorite Biomedical Inc. (4170.TWO) Enterprise Value vs. Peers

How is 4170.TWO’s Enterprise Value compared to its peers?

Vectorite Biomedical Inc.’s Enterprise Value is less than TaiwanJ Pharmaceuticals Co., Ltd. (610.53M), greater than Health & Life Co., Ltd. (546.95M), less than Pharmigene, Inc. (1.11B), less than BioLASCO Taiwan Co., Ltd. (811.96M), greater than Bioray Biotech Co., Ltd (502.94M), less than Eusol Biotech Co.,Ltd. (642.92M), less than DuoGenic StemCells corporation (680.91M), less than Sunder Biomedical Tech. Co., Ltd. (754.71M), less than SynCore Biotechnology Co.,Ltd (730.95M), less than Original BioMedicals Co., Ltd. (840.74M),

Build a custom stock screener for Vectorite Biomedical Inc. (4170.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vectorite Biomedical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vectorite Biomedical Inc. (4170.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vectorite Biomedical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.